Mega Lifesciences Public Company Limited
MEGA
Rank in Stocks
#9080
Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company... Established in Bangkok, Thailand, in 1982, Mega Lifesciences Public Company Limited, a subsidiary of Unistretch Limited, operates as a comprehensive pharmaceutical and wellness enterprise. Its primary activities encompass the development, promotion, and distribution of a broad spectrum of health-related products, including nutritional supplements, prescription medicines, over-the-counter (OTC) remedies, botanical solutions, vitamins, and everyday consumer goods. The company structures its operations across three main divisions: Brands, Distribution, and Original Equipment Manufacture. Mega Lifesciences offers an extensive array of complementary medicines targeting various health concerns such as bone and joint health, pediatric care, diabetes management, cardiovascular support, digestive and liver wellness, skin health, weight management, overall well-being, men's and women's specific needs, and sports nutrition. Its OTC portfolio addresses common issues like gastrointestinal discomfort and pain. Furthermore, the prescription drug division covers crucial therapeutic areas including iron deficiency, anticoagulation, diabetology, cardiology, dermatology, gastroenterology, neurology, pain relief, osteoporosis, respiratory conditions, urology, oncology, and nephrology. Beyond its proprietary product lines, the company also provides third-party logistical and marketing services. Additionally, Mega Lifesciences is involved in managing wellness centers and offers specialized services in software design, development, and related technological solutions. The company maintains a significant global footprint, with operations spanning the Asia Pacific region, the Middle East, Africa, and the Commonwealth of Independent States.
Share Price
$1.05
Last synced: 2026-11-10
Market Cap
$913.76M
Change (1 day)
-1.41%
Change (1 year)
14.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Mega Lifesciences Public Company Limited (MEGA)
Category
Healthcare
EPS for Mega Lifesciences Public Company Limited (MEGA)
EPS as of June 2026 TTM: $0.07
According to Mega Lifesciences Public Company Limited's latest financial reports, its current EPS (TTM) is $0.07. At the end of 2025 the company had an EPS of $0.07, equal to its 2024 EPS of $0.07.
EPS history for Mega Lifesciences Public Company Limited from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.07 | 6.29% |
| 2025 | $0.07 | 2.96% |
| 2024 | $0.07 | 1.65% |
| 2023 | $0.07 | -10.50% |
| 2022 | $0.07 | 10.57% |
| 2021 | $0.07 | 25.84% |
| 2020 | $0.05 | 21.09% |
| 2019 | $0.04 | 2.32% |
| 2018 | $0.04 | 8.56% |
| 2017 | $0.04 | 54.47% |
| 2016 | $0.03 | 15.77% |
| 2015 | $0.02 | 16.23% |
| 2014 | $0.02 | -25.68% |
| 2013 | $0.03 | -0.39% |
| 2012 | $0.03 | 31.63% |
| 2011 | $0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 8,638.44% |
DE
|
|
| $6.08 | 8,068.82% |
DE
|
|
| $1.55 | 1,984.14% |
JP
|
|
| $3.66 | 4,819.35% |
CH
|
|
| $0.45 | 504.84% |
IL
|
Questions about Mega Lifesciences Public Company Limited's earnings per share (EPS)
What is Mega Lifesciences Public Company Limited's earnings per share (EPS)?
Mega Lifesciences Public Company Limited's earnings per share (EPS) over the last twelve months is $0.07, as of Jun 2026.
What was Mega Lifesciences Public Company Limited's earnings per share (EPS) in 2025?
In 2025, Mega Lifesciences Public Company Limited's earnings per share (EPS) was $0.07, about the same as in 2024 ($0.07).
How has Mega Lifesciences Public Company Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Mega Lifesciences Public Company Limited's earnings per share (EPS) went from $0.05 to $0.07, an average growth of 6.96% a year.
How does Mega Lifesciences Public Company Limited's earnings per share (EPS) compare with similar companies?
Mega Lifesciences Public Company Limited's earnings per share (EPS) ($0.07) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.